GOHIBIC

This brand name is authorized in United States. It is also authorized in Lithuania.

Active ingredients

The drug GOHIBIC contains one active pharmaceutical ingredient (API):

`1`	Vilobelimab UNII `F5T0RF9ZJA` - VILOBELIMAB
	Vilobelimab is a chimeric human/mouse monoclonal IgG4 antibody that is a specific inhibitor of the soluble human complement component C5a.
	Read more about Vilobelimab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GOHIBIC Concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AJ10		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AJ Complement inhibitors
Discover more medicines within L04AJ10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1102332
US	FDA, National Drug Code	83000-110

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.